1. Home
  2. KE vs CTMX Comparison

KE vs CTMX Comparison

Compare KE & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$25.35

Market Cap

617.2M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.32

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
CTMX
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.2M
596.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
KE
CTMX
Price
$25.35
$4.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$28.00
$12.10
AVG Volume (30 Days)
120.4K
9.2M
Earning Date
05-05-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$1,486,727,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
$27.22
P/E Ratio
$46.09
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$0.40
52 Week High
$33.19
$8.21

Technical Indicators

Market Signals
Indicator
KE
CTMX
Relative Strength Index (RSI) 56.05 43.27
Support Level $23.38 $3.55
Resistance Level $31.17 $4.64
Average True Range (ATR) 1.03 0.59
MACD 0.40 -0.09
Stochastic Oscillator 88.67 3.75

Price Performance

Historical Comparison
KE
CTMX

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: